Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Sells $2.2B in Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has closed its offering of senior notes, raising $2.2 billion.

As reported last week, the firm offered $300 million aggregate principal amount of 2.05 percent senior notes due 2014; $900 million aggregate principal amount of 3.2 percent senior notes due 2016; and $1 billion aggregate principal amount of 4.5 percent senior notes due 2021.

The firm said in a filing today with the US Securities and Exchange Commission that the 2014 notes will mature on Feb. 21, 2014, the 2016 notes will mature on March 1, 2016, and the 2021 notes will mature on March 1, 2021.

Thermo Fisher will use the proceeds to pay for its $2.1 billion acquisition of Dionex, which was announced in December. Last week, the firm said that it had extended its tender offer to acquire all of the outstanding shares of Dionex for $118.50 per share until midnight, New York City time, on April 7.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.